Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Feb;25(2):273–275. doi: 10.1128/aac.25.2.273

Cefuroxime treatment of bacterial meningitis in infants and children.

S Sirinavin, S Chiemchanya, P Visudhipan, S Lolekha
PMCID: PMC185488  PMID: 6608921

Abstract

Recently, ampicillin- and chloramphenicol-resistant strains of Haemophilus influenzae type b and multiply-resistant Salmonella strains have appeared in some areas of the world. Therefore, alternative drug therapy for infections caused by these organisms is being sought. We used cefuroxime to successfully treat five children with H. influenzae type b meningitis and two children with Salmonella meningitis. Four H. influenzae type b isolates and one Salmonella isolate were resistant to ampicillin, chloramphenicol, and cotrimoxazole. Each of the patients received 200 to 250 mg of cefuroxime per kg per day in four divided doses for 14 to 21 days. The concentrations of cefuroxime in cerebrospinal fluid at 2 h after intravenous 50-mg/kg doses were 6.4 +/- 1.7 (mean +/- standard deviation) and 3.6 +/- 2.2 micrograms/ml on days 2 and 14 of treatment, respectively. The level of drug in cerebrospinal fluid was 1.34 +/- 1.3 micrograms/ml in children without meningitis. The mean cefuroxime concentration in subdural fluid samples from each of three patients was 12.6, 15, and 25.2 micrograms/ml. Cefuroxime is recommended as an alternative drug for the treatment of H. influenzae type b meningitis, but additional information is necessary before cefuroxime can be recommended for therapy of Salmonella meningitis.

Full text

PDF
274

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azimi P. H., Chase P. A. The role of cefamandole in the treatment of Haemophilus influenzae infections in infants and children. J Pediatr. 1981 Jun;98(6):995–1000. doi: 10.1016/s0022-3476(81)80616-6. [DOI] [PubMed] [Google Scholar]
  2. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  3. Kenny J. F., Isburg C. D., Michaels R. H. Meningitis due to Haemophilus influenzae type b resistant to both ampicillin and chloramphenicol. Pediatrics. 1980 Jul;66(1):14–16. [PubMed] [Google Scholar]
  4. Kinmonth A. L., Storrs C. N., Mitchell R. G. Meningitis due to chloramphenicol-resistant Haemophilus influenzae type b. Br Med J. 1978 Mar 18;1(6114):694–694. doi: 10.1136/bmj.1.6114.694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Long S. S., Phillips S. E. Chloramphenicol-resistant Hemophilus influenzae. J Pediatr. 1977 Jun;90(6):1030–1031. doi: 10.1016/s0022-3476(77)80592-1. [DOI] [PubMed] [Google Scholar]
  6. McCracken G. H., Jr, Nelson J. D., Grimm L. Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis. Antimicrob Agents Chemother. 1982 Feb;21(2):262–267. doi: 10.1128/aac.21.2.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Müller C., Netland A., Dawson A. F., Andrew E. The penetration of cefuroxime into the cerebrospinal fluid through inflamed and non-inflamed meninges. J Antimicrob Chemother. 1980 Mar;6(2):279–283. doi: 10.1093/jac/6.2.279. [DOI] [PubMed] [Google Scholar]
  8. Nelson J. D. The increasing frequency of beta-lactamase-producing Haemophilus influenzae B. JAMA. 1980 Jul 18;244(3):239–239. [PubMed] [Google Scholar]
  9. Pfenninger J., Schaad U. B., Lütschg J., Nussbaumer A., Zellweger U. Cefuroxime in bacterial meningitis. Arch Dis Child. 1982 Jul;57(7):539–543. doi: 10.1136/adc.57.7.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Simasathien S., Duangmani C., Echeverria P. Haemophilus influenzae type B resistant to ampicillin and chloramphenicol in an orphanage in Thailand. Lancet. 1980 Dec 6;2(8206):1214–1217. doi: 10.1016/s0140-6736(80)92478-2. [DOI] [PubMed] [Google Scholar]
  11. Thirumoorthi M. C., Kobos D. M., Dajani A. S. Susceptibility of Haemophilus influenzae to chloramphenicol and eight beta-lactam antibiotics. Antimicrob Agents Chemother. 1981 Aug;20(2):208–213. doi: 10.1128/aac.20.2.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Uchiyama N., Greene G. R., Kitts D. B., Thrupp L. D. Meningitis due to Haemophilus influenzae type b resistant to ampicillin and chloramphenicol. J Pediatr. 1980 Sep;97(3):421–424. doi: 10.1016/s0022-3476(80)80193-4. [DOI] [PubMed] [Google Scholar]
  13. del Rio M. de los A., Chrane D. F., Shelton S., McCracken G. H., Jr, Nelson J. D. Pharmacokinetics of cefuroxime in infants and children with bacterial meningitis. Antimicrob Agents Chemother. 1982 Dec;22(6):990–994. doi: 10.1128/aac.22.6.990. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES